Ter-Ovanessian B
ORCID: 0000-0002-1208-3689
· 1 paper in corpus
BackgroundIntroduced in 2002, the Essure® implant was promoted as a minimally invasive permanent contraceptive. After widespread use, increasing reports of adverse effects led to its global withdrawal in 2018. This study explores the experi…